These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2686419)

  • 1. Ciprofloxacin versus ceftazidime in serious infections.
    Reinhardt JF; Bacon AE; Winslow DL; Holloway WJ
    Am J Med; 1989 Nov; 87(5A):181S-182S. PubMed ID: 2686419
    [No Abstract]   [Full Text] [Related]  

  • 2. Ciprofloxacin versus ceftazidime in skin and soft tissue infections.
    Thadepalli H; Mathai D; Chuah SK; Bansal MB
    J Chemother; 1989 Feb; 1(1):30-4. PubMed ID: 2656929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intravenous ciprofloxacin with ceftazidime in the treatment of serious soft tissue infections.
    Tice AD; Marsh PK; Craven PC
    Diagn Microbiol Infect Dis; 1990; 13(2):165-7. PubMed ID: 2196153
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous ciprofloxacin and ceftazidime in serious infections. A prospective, controlled clinical trial with third-party blinding.
    Sifuentes-Osornio J; Macías A; Amieva RI; Ramos A; Ruiz-Palacios GM
    Am J Med; 1989 Nov; 87(5A):202S-205S. PubMed ID: 2686425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections.
    Khan FA; Basir R
    Chest; 1989 Sep; 96(3):528-37. PubMed ID: 2670465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intravenous ciprofloxacin in the treatment of serious infections. A comparison with ceftazidime.
    Quintero-Perez NP; Andrade-Villaneuva JF; Leon-Garnica G; Bertin-Montano M; Rodriguez-Chagollan JJ; Rodriguez-Noriega E
    Am J Med; 1989 Nov; 87(5A):198S-201S. PubMed ID: 2686424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative, double-blind study of intravenous ciprofloxacin and intravenous ceftazidime in serious infection.
    Ramirez-Ronda CH; Saavedra S; Rivera-Vazquez CR
    Am J Med; 1989 Nov; 87(5A):195S-197S. PubMed ID: 2686423
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections.
    Levine DP; McNeil P; Lerner SA
    Am J Med; 1989 Nov; 87(5A):160S-163S. PubMed ID: 2686416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous/oral ciprofloxacin therapy versus intravenous ceftazidime therapy for selected bacterial infections.
    Gaut PL; Carron WC; Ching WT; Meyer RD
    Am J Med; 1989 Nov; 87(5A):169S-175S. PubMed ID: 2686417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections.
    Peacock JE; Pegram PS; Weber SF; Leone PA
    Am J Med; 1989 Nov; 87(5A):185S-190S. PubMed ID: 2686421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infections.
    Gallis HA; Brennan RO; Goodwin SD; Swinney V; Rumbaugh MM; Drew RH
    Am J Med; 1989 Nov; 87(5A):176S-180S. PubMed ID: 2686418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure.
    Gentry LO; Koshdel A
    Am J Med; 1989 Nov; 87(5A):132S-135S. PubMed ID: 2686413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential intravenous/oral ciprofloxacin compared with intravenous ceftazidime in the treatment of serious lower respiratory tract infections.
    Menon L; Ernst JA; Sy ER; Flores D; Pacia A; Lorian V
    Am J Med; 1989 Nov; 87(5A):119S-120S. PubMed ID: 2686412
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous ciprofloxacin or ceftazidime in selected infections. A prospective, randomized, controlled study.
    Villavicencio J; Asensio de Fernandez ME; Ramirez CA
    Am J Med; 1989 Nov; 87(5A):191S-194S. PubMed ID: 2686422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.
    Fass RJ; Plouffe JF; Russell JA
    Am J Med; 1989 Nov; 87(5A):164S-168S. PubMed ID: 2589361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever.
    Bayston KF; Want S; Cohen J
    Am J Med; 1989 Nov; 87(5A):269S-273S. PubMed ID: 2686428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacterial infections in cancer patients].
    Krankenpfl J; 2005; 43(1-3):42-3. PubMed ID: 15912833
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous and oral ciprofloxacin versus intravenous ceftazidime for the treatment of severe urinary tract infections.
    Childs SJ
    Diagn Microbiol Infect Dis; 1990; 13(2):161-3. PubMed ID: 2196152
    [No Abstract]   [Full Text] [Related]  

  • 19. Parenteral ciprofloxacin compared with ceftazidime in the treatment of serious upper and lower urinary tract infection.
    Palmer DL; Koster FT
    Diagn Microbiol Infect Dis; 1990; 13(2):157-60. PubMed ID: 2196151
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections.
    Trenholme GM; Schmitt BA; Spear J; Gvazdinskas LC; Levin S
    Am J Med; 1989 Nov; 87(5A):116S-118S. PubMed ID: 2686411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.